Soleno Therapeutics Inc (SLNO)
EBITDA Margin
37.55%
TTM · Period ending:
SLNO EBITDA Margin
Latest reported37.55%period ending
Latest reported37.55%period ending
SLNO TTM EBITDA Margin (-29.47% → 37.55%)
TTM ebitda margin
High-resolution chart · PNG
SLNO ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 37.5463% | |
| 14.9066% | |
| -67.1994% | |
| -529.8986% | |
| -1.4734% | |
| -1.339% | |
| -1.2748% | |
| -1.0974% | |
| -1,545.5703% | |
| -939.2891% | |
| -631.1031% | |
| -757.9577% | |
| -844.8032% | |
| -1,126.5812% | |
| -1,717.609% | |
| -3,128.4638% | |
| -7,194.6664% | |
| -15,913.3574% | |
| -31,205.5136% | |
| -29.4669% |